Streetbeat News

HRST

Harvest Oil & Gas Corp

https://hvstog.com/

Employees

Industry

Crude Petroleum and Natural Gas Extraction

Open

2.76

Mkt cap

2.8M

Volume

High

2.76

P/E Ratio

-0.19

52-wk high

6.00

Low

2.72

Div yield

N/A

52-wk low

2.01

Tema has launched the Tema Cardiovascular and Metabolics ETF (HRST) focusing on companies like Novo Nordisk (NVO), which makes Ozempic, and Eli Lilly (LLY), maker of Mounjaro. Semaglutides, including Ozempic and Mounjaro, have shown significant weight loss and organ protection benefits. NVO's stock has surged 281% since Ozempic's 2019 launch, while LLY's shares jumped nearly 80% post-Mounjaro's 2022 launch. In contrast, Pfizer (PFE), without a semaglutide, has seen a 51% decline since December 2021. HRST aims to capitalize on the lucrative cardiovascular and obesity treatment market, also including companies like Masimo (MASI) and Madrigal Pharmaceuticals (MDGL).

Portfolio Pulse from Neil Dennis

November 21, 2023 | 1:55 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.